A detailed history of Hudson Bay Capital Management LP transactions in Alkermes Plc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 25,000 shares of ALKS stock, worth $741,250. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,000
Previous 30,000 16.67%
Holding current value
$741,250
Previous $723,000 3.32%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$23.01 - $28.55 $115,050 - $142,750
-5,000 Reduced 16.67%
25,000 $699,000
Q2 2024

Aug 14, 2024

BUY
$23.21 - $27.24 $696,300 - $817,200
30,000 New
30,000 $723,000
Q4 2022

Feb 14, 2023

BUY
$21.94 - $26.24 $658,200 - $787,200
30,000 New
30,000 $783,000
Q3 2020

Nov 12, 2020

SELL
$16.16 - $20.66 $969,600 - $1.24 Million
-60,000 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$13.31 - $19.41 $798,600 - $1.16 Million
60,000 New
60,000 $1.16 Million
Q1 2020

May 14, 2020

SELL
$13.06 - $21.24 $914,200 - $1.49 Million
-70,000 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$19.51 - $24.28 $97,550 - $121,400
-5,000 Reduced 6.67%
70,000 $1.37 Million
Q2 2019

Aug 14, 2019

BUY
$21.47 - $37.33 $1.61 Million - $2.8 Million
75,000 New
75,000 $1.69 Million
Q1 2018

May 14, 2018

SELL
$53.61 - $67.26 $2.68 Million - $3.36 Million
-50,000 Closed
0 $0
Q4 2017

Feb 12, 2018

SELL
$47.69 - $55.39 $476,900 - $553,900
-10,000 Reduced 16.67%
50,000 $2.74 Million
Q3 2017

Nov 13, 2017

BUY
$49.16 - $54.45 $2.95 Million - $3.27 Million
60,000
60,000 $3.05 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.87B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.